Associate Professor, Psychiatry, Perelman School of Medicine
Psychiatry
Dr. Charles A. Dackis, MD
|
|
Give Review
Charles A. Dackis practices Psychiatry. He went to medical school at Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Charles Dackis is also published. He has 80 publications published. The lastest publication: "Platelet MAO activity in schizophrenia and other psychiatric illnesses.' He is registered with Medicare.
Publications
- The Dopamine Receptor D2 (DRD2) SNP rs1076560 is Associated with Opioid Addiction.
- Low frequency genetic variants in the ?-opioid receptor (OPRM1) affect risk for addiction to heroin and Cocaine.
- Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with Cocaine and opioid addicted populations.
- Genetic association analyses of PDYN polymorphisms with heroin and Cocaine addiction.
- Further evidence for association of polymorphisms in the CNR1 gene with Cocaine addiction: confirmation in an independent sample and meta-analysis.
- A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and Alcohol dependence.
- Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine Dependence.
- Gender differences with high-dose naltrexone in patients with co-occurring cocaine and Alcohol dependence.
- The status of naltrexone in the treatment of Alcohol dependence: specific effects on heavy drinking.
- Does modafinil produce euphoria?
- Clinical implications of Cocaine-induced cortical depression.
- A double-blind, placebo-controlled trial of modafinil for cocaine Dependence.
- Recent advances in the pharmacotherapy of cocaine Dependence.
- Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of Cocaine patients.
- Cocaine Dependence: a disease of the brain's reward centers.
- A commentary on "The role of laboratory tests for Alcoholism treatment".
- Opiate Addiction and depression--cause or effect?
- The dexamethasone suppression test for Major depression among opiate addicts.
- Addison's disease initially diagnosed as bereavement and conversion Disorder.
- Platelet serotonin transporter in Cocaine patients.
- Specificity of the DST and the TRH test for major depression in Alcoholics.
- The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in Alcoholics.
- New insights and treatments: opiate withdrawal and Cocaine addiction.
- The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
- Naltrexone, opiate Addiction, and endorphins.
- Persistence of urinary marijuana levels after supervised abstinence.
- Urinary excretion of noradrenaline metabolite decreased in panic Disorder.
- Methadone induced hypoadrenalism.
- Drug abuse and bipolar Disorders.
- Evaluating depression in Alcoholics.
- Cocaine abuse: neurochemistry, phenomenology, and treatment.
- Specificity of the TRH test for major depression in patients with serious Cocaine abuse.
- Cocaine update: from bench to bedside.
- Pharmacological approaches to Cocaine addiction.
- Bromocriptine treatment for Cocaine abuse: the dopamine depletion hypothesis.
- The adolescent Cocaine epidemic.
- The physiology of Cocaine craving and 'crashing'.
- More on self-medication and Drug abuse.
- Propranolol and stuttering.
- Sexual dysfunction secondary to Cocaine abuse in two patients.
- Single-dose bromocriptine reverses Cocaine craving.
- Bromocriptine.
- Dexamethasone suppression test testing of depressed Alcoholics.
- Role of the laboratory in the evaluation of suspected Drug abuse.
- The relationship of addiction, tolerance, and dependence to Alcohol and drugs: a neurochemical approach.
- Opinion: clinical use of urine testing in relapse prevention.
- New concepts in Cocaine addiction: the dopamine depletion hypothesis.
- Central stimulant abuse: neurochemistry and pharmacotherapy.
- Bromocriptine as treatment of Cocaine abuse.
- Neurotransmitter and neuroendocrine abnormalities associated with Cocaine use.
- Addictiveness of central stimulants.
- Multidimensional scaling of musks.
- Platelet MAO activity in schizophrenia and other psychiatric Illnesses.
- In vivo inhibition of platelet MAO activity by tricyclic antidepressants.
- Reduced olfactory discrimination in patients on chronic hemodialysis.
- Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine Dependence.
- Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine Dependence.
- Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine Dependence.
- Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine Dependence.
- Modafinil and Cocaine: a double-blind, placebo-controlled drug interaction study.
- A pilot trial of topiramate for the treatment of cocaine Dependence.
- Glutamatergic agents for cocaine Dependence.
- A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine Dependence.
- A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine Dependence in patients with severe cocaine with...
- Injectable, sustained-release naltrexone for the treatment of opioid Dependence: a randomized, placebo-controlled trial.
- Neurobiology of Addiction: treatment and public policy ramifications.
- No association between polymorphisms in the prostate apoptosis factor-4 gene and cocaine Dependence.
- Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine Dependence.
- A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B Alcoholism.
- Outcome predictors in cocaine Dependence treatment trials.
- A placebo-controlled trial of modafinil for nicotine Dependence.
- A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.
- Cocaine withdrawal symptoms identify "Type B" Cocaine-dependent patients.
- A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and Alcohol dependence.
- Initiating acamprosate within-detoxification versus post-detoxification in the treatment of Alcohol dependence.
- Predictors of treatment outcome in outpatient cocaine and Alcohol dependence treatment.
- Modafinil for the treatment of cocaine Dependence.
- A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine Dependence.
- Normalizing effects of modafinil on Cocaine-induced sleep abnormalities.
Schools
Duke University
Overlook Hospital
Colum Presby Med Center
Colum Presby
Procedures Preformed
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Anxiety
- Bipolar Disorder
- View All
Doctors Specialties
- Addiction Psychiatry
- Psychiatry
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Duke University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1922034628 | |
| NPPES Provider LastName | DACKIS | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 191042640 | |
| NPPES Provider State | PA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 56.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922034628 |
| Last Name Of The Provider | DACKIS |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Martin W. Vetter, MD
 This Doctor is OpenDoctor Recommended.
|
|
Christopher J. Pagnani, BCD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayesha Waheed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rocksheng Zhong, MD |
|
|
Dr. John Listerud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Lache, MD |
|
|
Dr. Yu-Heng Guo, MD |
|
|
Dr. Donald J. Kushon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward M. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Max M. Hughes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry R. Kranzler, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jeffrey D. Bedrick, MD
This Doctor is OpenDoctor Recommended.
|